Firebrick Pharma Ltd (FRE) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.759x

Based on the latest financial reports, Firebrick Pharma Ltd (FRE) has a cash flow conversion efficiency ratio of -0.759x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.18 Million ≈ $-836.31K USD) by net assets (AU$1.56 Million ≈ $1.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Firebrick Pharma Ltd - Cash Flow Conversion Efficiency Trend (2019–2025)

This chart illustrates how Firebrick Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read FRE total debt and obligations for a breakdown of total debt and financial obligations.

Firebrick Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Firebrick Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Takuni Group Public Company Limited BK:TAKUNI	0.475x
Nala Digital Commerce Ltd TA:NALA	-0.080x
Dataworks Group Ltd AU:DWG	-32.658x
Bhakti Agung Propertindo JK:BAPI	-0.002x
Magle Chemoswed Holding Ab ST:MAGLE	-0.092x
Sahathai Terminal Public Company Limited BK:PORT	0.073x
European Electric Metals Inc V:EVX	-0.631x
Acme Holdings Bhd KLSE:7131	0.088x

Annual Cash Flow Conversion Efficiency for Firebrick Pharma Ltd (2019–2025)

The table below shows the annual cash flow conversion efficiency of Firebrick Pharma Ltd from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Firebrick Pharma Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$1.56 Million ≈ $1.10 Million	AU$-1.78 Million ≈ $-1.26 Million	-1.143x	-3.12%
2024-06-30	AU$2.12 Million ≈ $1.50 Million	AU$-2.34 Million ≈ $-1.66 Million	-1.109x	+52.54%
2023-06-30	AU$2.48 Million ≈ $1.75 Million	AU$-5.78 Million ≈ $-4.09 Million	-2.336x	-360.20%
2022-06-30	AU$8.28 Million ≈ $5.86 Million	AU$-4.20 Million ≈ $-2.97 Million	-0.508x	-202.88%
2021-06-30	AU$11.55 Million ≈ $8.17 Million	AU$-1.94 Million ≈ $-1.37 Million	-0.168x	+93.35%
2020-06-30	AU$390.60K ≈ $276.37K	AU$-985.01K ≈ $-696.96K	-2.522x	-155.58%
2019-06-30	AU$1.08 Million ≈ $763.34K	AU$-1.06 Million ≈ $-753.18K	-0.987x	--

About Firebrick Pharma Ltd

AU:FRE Australia Drug Manufacturers - General

Market Cap

$9.47 Million

AU$13.38 Million AUD

Market Cap Rank

#26999 Global

#1355 in Australia

Share Price

AU$0.05

Change (1 day)

+0.00%

52-Week Range

AU$0.05 - AU$0.08

All Time High

AU$0.65